Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Rivaroxaban impurity 1 is a known drug impurity related to Rivaroxaban, a selective inhibitor of factor Xa. This impurity is critical for analytical chemistry applications, particularly in the quality control and characterization of Rivaroxaban in pharmaceutical formulations. It serves as a reference standard for assessing the purity and stability of Rivaroxaban compounds in research and development settings. -
Drug Impurity
Oxcarbazepine impurity 2 is a recognized impurity associated with the anticonvulsant drug oxcarbazepine. Its main application lies in the assessment of drug purity and quality control during the pharmaceutical development process. Understanding and characterizing this impurity is crucial for ensuring the safety and efficacy of pharmaceutical formulations containing oxcarbazepine. -
Drug Intermediate
2-(Pyridin-2-yl)benzo[d]oxazol-5-amine is a versatile drug intermediate that facilitates the synthesis of diverse active pharmaceutical compounds. This compound plays a key role in pharmaceutical development and can be utilized in medicinal chemistry to create novel therapeutic agents. Its ability to participate in various chemical reactions makes it valuable for researchers focused on drug discovery and development. -
Drug Intermediate
1-Oxa-7-azaspiro[4.5]decan-2-one hydrochloride serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This chemical is instrumental in medicinal chemistry and pharmaceutical research, facilitating the development of novel therapeutics. Its unique structural properties make it a valuable building block for various applications in drug discovery. -
Drug Intermediate
1-(2-Nitrophenyl)piperidin-2-one serves as a crucial drug intermediate for the synthesis of diverse bioactive molecules. This compound is instrumental in the production of pharmaceuticals and other active chemical entities, aiding in the development of therapeutic agents. Its unique structure allows for effective modifications to yield compounds with desirable biological properties, making it an essential reagent in chemical research and development. -
Drug Intermediate
(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid acts as a drug intermediate involved in the synthesis of diverse active pharmaceutical ingredients. Its structural properties facilitate the development of complex compounds, contributing significantly to medicinal chemistry research. This reagent is invaluable for studies focused on drug design and optimization. -
Drug Intermediate
Cis-1-Benzyl-3,5-dimethyl-4-oxopiperidine serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This piperidine derivative facilitates the development of new therapeutic agents by providing a versatile scaffold for further chemical modifications. Its structural attributes and reactivity make it a valuable resource for medicinal chemistry and pharmaceutical research applications. -
Drug Intermediate
6-Bromo-2-chloroquinolin-4-amine functions as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This chemical plays a significant role in medicinal chemistry, facilitating the development of novel therapeutics. Its structural characteristics contribute to various biological activities, making it a valuable reagent for researchers exploring drug discovery and development pathways. -
Drug Impurity
3-Methyl-2H-indazol-6-amine is a chemical compound commonly identified as a drug impurity. Its presence in pharmaceutical formulations may influence the safety and efficacy of active compounds. Research applications include the assessment of pharmaceutical quality and the study of impurity effects on drug performance and stability. -
Drug Intermediate
(3-(5-Bromopyrimidin-2-yl)phenyl)methanol functions as a key intermediate in the synthesis of diverse bioactive compounds. It serves as a pivotal building block in pharmaceutical research, facilitating the development of novel therapeutic agents. This compound is essential for studies focusing on drug design and medicinal chemistry. -
Drug Impurity
2-(2,2,2-Trifluoroethoxy)pyridin-3-amine is identified as a drug impurity with a potential impact on drug development and safety assessments. It serves as a valuable reference standard for analytical methods such as HPLC and LC-MS. Researchers may utilize this compound to better understand the metabolic pathways and toxicity profiles of related pharmaceutical agents. -
Drug Impurity
Rivaroxaban impurity 6 is a known impurity related to the anticoagulant Rivaroxaban, acting primarily as a drug impurity marker. This compound is crucial for analytical applications, particularly in the validation and quality control of pharmaceutical formulations containing Rivaroxaban. Its presence and quantification are essential for ensuring compliance with regulatory standards in drug development and manufacturing processes. -
Drug Intermediate
Ethyl 4-(cyclopropylamino)cyclohexanecarboxylate is a chemical intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. Its structural framework facilitates the development of compounds with potential therapeutic applications. This reagent is of particular interest in medicinal chemistry for the creation of novel entities targeting various biological pathways. -
Drug Impurity
Cinacase impurity 12 is a chemical impurity associated with the synthesis of Cinacase. This compound is relevant in the pharmaceutical industry for quality control and assessment of drug formulations. It aids in understanding the impurity profile of Cinacase, which is essential for ensuring the safety and efficacy of the final pharmaceutical product. -
Drug Impurity
Ticagrelor impurity 11 is a known impurity associated with Ticagrelor, a potent P2Y12 adenosine diphosphate receptor antagonist. This compound may be utilized in analytical studies to assess the purity of Ticagrelor formulations, contributing to quality control and regulatory compliance in pharmaceuticals. Its characterization can provide insights into the stability and degradation pathways of Ticagrelor, aiding researchers in understanding its chemical behavior and efficacy. -
Drug Impurity
Remimazolam impurity 4 is a known impurity associated with the anesthetic compound Remimazolam. It is characterized by its potential effects on the pharmacological profile of the parent compound. This impurity is significant for research applications related to drug formulation, stability testing, and safety assessment in pharmacokinetic studies. Understanding its properties can help ensure the quality and efficacy of anesthetic products. -
Drug Impurity
Favipiravir impurity 5 is a characterized impurity of the antiviral compound Favipiravir, known for its activity against various RNA viruses. This reagent plays a critical role in the assessment of drug quality and stability during pharmaceutical development. Favipiravir impurity 5 is essential for analytical studies aimed at understanding the implications of impurities on drug efficacy and safety. -
Drug Intermediate
5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1-carboxylic acid is a key drug intermediate utilized in the synthesis of diverse bioactive compounds. This compound plays a critical role in pharmaceutical research, facilitating the development of novel therapeutic agents. Its unique structure renders it valuable in various synthetic pathways, aiding in the exploration of innovative drug candidates. -
Drug Impurity
Tofacitinib impurity 4 is a chemical impurity related to Tofacitinib, an oral Janus kinase (JAK) inhibitor. This impurity may be useful for characterization studies, quality control, and impurity profiling in the development and manufacturing of Tofacitinib. It provides valuable insights into the pharmaceutical formulation and stability of the drug, assisting researchers in ensuring safety and efficacy standards. -
Drug Intermediate
4-(4-Bromophenyl)piperidin-2-one is a substituted piperidinone that serves as a versatile drug intermediate in the synthesis of bioactive compounds. This compound is integral in pharmaceutical research and development, facilitating the creation of diverse therapeutic agents. Its structural properties enable modifications that can enhance biological activity across various targets, making it valuable in medicinal chemistry. -
Drug Intermediate
5-Fluoro-2-(1H-pyrrol-1-yl)aniline serves as a critical drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its unique structure allows for effective modifications, facilitating the development of therapeutics with enhanced potency and specificity. This reagent is valuable in medicinal chemistry for research applications focused on novel drug discovery and optimization processes. -
Drug Intermediate
Fmoc-pro-osu is an N-Fmoc-L-proline N-succinimidyl ester that serves as a versatile drug intermediate in the synthesis of various active pharmaceutical compounds. This reagent facilitates the introduction of proline residues into peptide chains, thereby enhancing the structural diversity and biological activity of the resultant molecules. Fmoc-pro-osu is particularly valuable in peptide chemistry and drug development, contributing to a range of research applications in medicinal chemistry. -
Drug Impurity
Afatinib impurity 17 is a known impurity associated with Afatinib, a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinases. This compound is primarily used in the characterization and quality control of pharmaceutical formulations containing Afatinib. Its analysis is crucial for ensuring compliance with regulatory standards and assessing the purity of drug substances in research and development. -
Drug Intermediate
Diethyl 2-bromoglutarate is a versatile drug intermediate primarily utilized in the synthesis of various bioactive compounds. It exhibits a reactive bromine moiety that facilitates nucleophilic substitution reactions, making it valuable in medicinal chemistry and drug discovery. This compound is relevant in the development of pharmaceuticals and biologically active molecules. -
Drug Intermediate
2-(2-(Pyridin-2-yl)-1H-imidazol-4-yl)ethan-1-amine dihydrochloride serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This reagent is integral to the development of pharmacologically relevant molecules, facilitating research in medicinal chemistry and drug discovery. Its structural elements are designed to enhance interactions with biological targets, making it valuable for studies in therapeutic applications. -
Drug Intermediate
4-(Hydroxymethyl)oxane-4-carbonitrile serves as a crucial drug intermediate in the synthesis of various bioactive compounds. Its structural features facilitate the formation of complex molecules, making it valuable in pharmaceutical research and development. This reagent is particularly relevant for studies focusing on the design and production of potential therapeutic agents. -
Drug Intermediate
tert-Butyl 3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)pyrrolidine-1-carboxylate acts as a critical drug intermediate in the synthesis of diverse pharmaceutical compounds. Its structure facilitates the development of biologically active molecules, making it a valuable reagent in medicinal chemistry research. This compound provides essential components for the generation of innovative therapeutic agents targeting various diseases. -
Drug Intermediate
5-Chloromethyl-1-propyl-1H-imidazole hydrochloride serves as a versatile drug intermediate utilized in the synthesis of a variety of active pharmaceutical compounds. Its unique structure allows for significant modifications, making it a valuable building block in medicinal chemistry. This reagent can facilitate the development of new therapeutic agents through its application in pharmacological research and drug discovery. -
Drug Intermediate
(1R,2S,4R)-rel-1-Azabicyclo[2.2.1]heptane-2-carboxylic acid hydrochloride serves as an important drug intermediate in the synthesis of diverse bioactive compounds. This bicyclic structure facilitates the development of novel pharmaceuticals, contributing to advancements in medicinal chemistry. Its unique properties make it suitable for various research applications, including the exploration of therapeutic agents targeting neurological disorders. -
Drug Impurity
Suvorexant impurity 2 is a known impurity of the sleep aid Suvorexant, functioning as a competitive antagonist of orexin receptors. This compound is primarily utilized in chemical analysis and quality control of Suvorexant formulations, as well as in the study of drug metabolism and stability. Its presence is critical for ensuring the purity and efficacy of pharmaceutical products containing Suvorexant. -
Drug Intermediate
Tropone, also known as Cycloheptatrienone, serves as a crucial drug intermediate in the biosynthesis of various tropane-type natural products. This non-benzene aromatic compound is a derivative of tropane and is directly involved in the formation of compounds such as Tropolone and Tropodithietic acid. Its unique structure and reactivity make it valuable for research applications in organic synthesis and the development of therapeutics. -
Drug Impurity
(S)-Cinacalcet hydrochloride is a drug impurity associated with cinacalcet, a calcimimetic agent that targets the calcium-sensing receptor. This compound is primarily utilized in research to study drug metabolism, stability, and safety profiles of cinacalcet formulations. Its analysis is critical for ensuring the quality and regulatory compliance of pharmaceutical developments. -
Drug Intermediate
2-Cyclohexyl-4-methylphenol serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its chemical structure facilitates the development of compounds with varied biological activities. This reagent is essential for researchers engaged in medicinal chemistry and drug discovery initiatives. -
Drug Intermediate
tert-Butyl ((S)-1-amino-3-((R)-tetrahydro-2H-pyran-3-yl)propan-2-yl)(methyl)carbamate serves as a versatile drug intermediate in the synthesis of diverse bioactive compounds. Its structural features facilitate the development of molecules with potential therapeutic applications, including the modulation of biological pathways. This reagent is essential for researchers engaged in medicinal chemistry and the development of novel pharmaceuticals. -
Drug Intermediate
5-Chloro-4-formyl-3-methyl-1-phenylpyrazole serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This pyrazole derivative is utilized in various research applications focusing on the development of novel therapeutics. Its structural features make it a versatile building block for the fabrication of complex molecules in medicinal chemistry. -
Drug Intermediate
(S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine dihydrochloride serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structure facilitates the incorporation of pyrazole and pyridine motifs, which are associated with various biological activities. This reagent is particularly valuable in the development of novel therapeutic agents and can be utilized in medicinal chemistry research to explore new drug candidates. -
Drug Intermediate
3-Oxo-2,3-dihydro-1H-indazole-5-carboxylic acid is a key drug intermediate utilized in the synthesis of diverse bioactive compounds. Its structural features promote the development of various pharmaceuticals, making it a valuable building block in medicinal chemistry. This compound serves as a foundation for the synthesis of innovative therapeutics, supporting research applications in drug discovery and development. -
Drug Intermediate Control
2-Chloro-N-methyl-N-(4-nitrophenyl)acetamide is a synthetic intermediate primarily utilized in drug synthesis. It serves as a key building block in the development of pharmaceutical compounds, facilitating the introduction of specific chemical functionalities. Its properties make it valuable for various applications in organic and medicinal chemistry. -
Drug Intermediate
(S)-(4-Benzylmorpholin-2-yl)methanamine serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its unique structural features facilitate chemical modifications, making it a critical component in the development of various therapeutic agents. This compound is instrumental in advancing research in medicinal chemistry and drug development. -
Drug Intermediate
Diethyl benzylmalonate is a versatile drug intermediate that facilitates the synthesis of central inhibitory agents. Its structure allows for modification and incorporation into pharmacologically active compounds, making it valuable in medicinal chemistry research and the development of new therapeutic agents. -
Drug Intermediate
1,1'-Dibromoferrocene serves as a versatile drug synthesis intermediate for the development of 1,2-disubstituted ferrocenes. Its unique bifunctional structure facilitates various chemical modifications, making it a valuable reagent in synthetic organic chemistry. This compound is particularly useful in studies aimed at exploring the biological activities and therapeutic potentials of ferrocene derivatives. -
Drug Intermediate
2-Cyanoethylhydrazine is a chemical intermediate predominantly utilized in drug synthesis. It serves as a precursor for the development of antagonists targeting the opioid receptor-like 1 (ORL1), contributing to research in pain management and addiction studies. Its versatile use in the synthesis of bioactive compounds makes it a valuable reagent in pharmaceutical development applications. -
Drug Intermediate
1-Benzylpyrrole-2,5-dione is a heterocyclic compound featuring a maleimide ring and a benzyl group, serving as an effective drug intermediate. This compound demonstrates significant reactivity, enabling its use in the green chemical modification of cellulose nanocrystals (CNC), which is essential for enhancing the functionality of bio-based materials. It is suitable for research applications involving organic synthesis and material science. -
Drug Intermediate
4-Bromo-2-methoxyphenol is a versatile pharmaceutical intermediate employed in the synthesis of 2-(o-Tolyloxy)-5-hexylphenol (PT-70). Its unique structure facilitates various chemical transformations, making it a valuable reagent in medicinal chemistry research. This compound plays a critical role in the development of novel therapeutics and contributes to advancements in drug discovery. -
Drug Impurity
Rivastigmine impurity 12 (m-Methoxyacetophenone) is a known impurity associated with Rivastigmine, an acetylcholinesterase inhibitor used in the treatment of Alzheimer's disease. This compound serves as a valuable reference material for analytical chemistry applications, particularly in the development and validation of analytical methods for drug quality control. Its characterization contributes to ensuring the safety and efficacy of pharmaceutical formulations containing Rivastigmine. -
Drug Intermediate
3,5-Dihydroxyacetophenone is an important drug intermediate utilized in the synthesis of the active stilbene dimer, dehydro-δ-viniferin. This compound plays a pivotal role in the development of various pharmaceuticals and is of particular interest in studies involving its biological activity and potential therapeutic applications. Researchers can leverage this reagent to explore its effects in drug formulation and related biochemical pathways. -
Drug Intermediate
5-Bromo-2-fluoro-3-methylpyridine serves as a valuable intermediate in drug synthesis, particularly in the development of dihydroorotate dehydrogenase (DHODH) inhibitors. This compound is instrumental in the production of therapeutic agents targeting various diseases, including autoimmune disorders and cancer. Its unique structure facilitates modifications, enabling the design of potent bioactive molecules in medicinal chemistry research. -
Drug Intermediate
8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione serves as an important drug intermediate in the synthesis of various bioactive compounds. Its purine structure allows for potential applications in medicinal chemistry and pharmaceutical development. This compound can be utilized in the creation of therapeutics, enhancing the development of novel drug candidates for diverse biological targets. -
Drug Intermediate
4-((tert-Butoxycarbonyl)amino)nicotinic acid serves as a vital drug intermediate in the synthesis of various bioactive compounds. Its structure facilitates the introduction of amino functionalities in complex molecular architectures, making it essential in pharmaceutical research and development. This reagent is particularly valuable in the preparation of nicotinic acid derivatives, contributing to the exploration of their pharmacological properties. -
Drug Intermediate
3-Bromo-4-chloro-5-methoxybenzoic acid serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound may be utilized in the development of biologically active molecules, aiding research in medicinal chemistry and drug design. Its unique molecular structure facilitates modifications that can enhance pharmacological profiles in various therapeutic areas.
